Myasthenia Gravis: Overview and Treatment
Inflammatory Bowel Disease IV: Pharmacological Management
Cancer Therapies
iPS Cell Differentiation
Classification of Skeletal Muscle Relaxants
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 14, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Alvaro Cobo-Calvo1, Mar Tintore2
1Neurology Department, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
No abstract available in PubMed .